|
1
|
Gripp S, Mjartan S, Boelke E and Willers
R: Palliative radiotherapy tailored to life expectancy in end-stage
cancer patients: Reality or myth? Cancer. 116:3251–3256. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nieder C, Angelo K, Dalhaug A, Pawinski A,
Haukland E and Norum J: Palliative radiotherapy during the last
month of life: Predictability for referring physicians and
radiation oncologists. Oncol Lett. 10:3043–3049. 2015.PubMed/NCBI
|
|
3
|
Chow E, Abdolell M, Panzarella T, Harris
K, Bezjak A, Warde P and Tannock I: Validation of a predictive
model for survival in metastatic cancer patients attending an
outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol
Phys. 73:280–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krishnan MS, Epstein-Peterson Z, Chen YH,
Tseng YD, Wright AA, Temel JS, Catalano P and Balboni TA:
Predicting life expectancy in patients with metastatic cancer
receiving palliative radiotherapy: The TEACHH model. Cancer.
120:134–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mizumoto M, Harada H, Asakura H, Hashimoto
T, Furutani K, Hashii H, Takagi T, Katagiri H, Takahashi M and
Nishimura T: Prognostic factors and a scoring system for survival
after radiotherapy for metastases to the spinal column: A review of
544 patients at Shizuoka cancer center hospital. Cancer.
113:2816–2822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tseng YD, Krishnan MS, Sullivan AJ, Jones
JA, Chow E and Balboni TA: How radiation oncologists evaluate and
incorporate life expectancy estimates into the treatment of
palliative cancer patients: A survey-based study. Int J Radiat
Oncol Biol Phys. 87:471–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagai S, Abouljoud MS, Kazimi M, Brown KA,
Moonka D and Yoshida A: Peritransplant lymphopenia is a novel
prognostic factor in recurrence of hepatocellular carcinoma after
liver transplantation. Transplantation. 97:694–701. 2014.PubMed/NCBI
|
|
10
|
Vaduganathan M, Ambrosy AP, Greene SJ,
Mentz RJ, Subacius HP, Maggioni AP, Swedberg K, Nodari S, Zannad F,
Konstam MA, et al: Predictive value of low relative lymphocyte
count in patients hospitalized for heart failure with reduced
ejection fraction: Insights from the EVEREST trial. Circ Heart
Fail. 5:750–758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kovesdy CP, George SM, Anderson JE and
Kalantar-Zadeh K: Outcome predictability of biomarkers of
protein-energy wasting and inflammation in moderate and advanced
chronic kidney disease. Am J Clin Nutr. 90:407–414. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hyodo I, Morita T, Adachi I, Shima Y,
Yoshizawa A and Hiraga K: Development of a predicting tool for
survival of terminally ill cancer patients. Jpn J Clin Oncol.
40:442–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin Y, Ye X, He C, Zhang B and Zhang Y:
Pretreatment neutrophil-to-lymphocyte ratio as predictor of
survival for patients with metastatic nasopharyngeal carcinoma.
Head Neck. 37:69–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Giorgi U, Rihawi K, Aieta M, Lo Re G,
Sava T, Masini C, Baldazzi V, De Vincenzo F, Camerini A, Fornarini
G, et al: Lymphopenia and clinical outcome of elderly patients
treated with sunitinib for metastatic renal cell cancer. J Geriatr
Oncol. 5:156–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Le Scodan R, Massard C, Mouret-Fourme E,
Guinebretierre JM, Cohen-Solal C, De Lalande B, Moisson P,
Breton-Callu C, Gardner M, Goupil A, et al: Brain metastases from
breast carcinoma: Validation of the radiation therapy oncology
group recursive partitioning analysis classification and
proposition of a new prognostic score. Int J Radiat Oncol Biol
Phys. 69:839–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kikuchi N, Ohmori K, Kuriyama S, Shimada
A, Nakaho T, Yamamuro M and Tsuji I: Survival prediction of
patients with advanced cancer: The predictive accuracy of the model
based on biological markers. J Pain Symptom Manage. 34:600–606.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmidt H, Suciu S, Punt CJ, Gore M, Kruit
W, Patel P, Lienard D, von der Maase H, Eggermont AM, Keilholz U,
et al: Pretreatment levels of peripheral neutrophils and leukocytes
as independent predictors of overall survival in patients with
American joint committee on cancer stage IV melanoma: ReSults of
the EORTC 18951 biochemotherapy trial. J Clin Oncol. 25:1562–1569.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teramukai S, Kitano T, Kishida Y, Kawahara
M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, et al:
Pretreatment neutrophil count as an independent prognostic factor
in advanced non-small-cell lung cancer: An analysis of Japan
multinational trial organisation LC00-03. Eur J Cancer.
45:1950–1958. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He JR, Shen GP, Ren ZF, Qin H, Cui C,
Zhang Y, Zeng YX and Jia WH: Pretreatment levels of peripheral
neutrophils and lymphocytes as independent prognostic factors in
patients with nasopharyngeal carcinoma. Head Neck. 34:1769–1776.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Absenger G, Szkandera J, Pichler M, Stotz
M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H,
Stojakovic T and Gerger A: A derived neutrophil to lymphocyte ratio
predicts clinical outcome in stage II and III colon cancer
patients. Br J Cancer. 109:395–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Templeton AJ, Pezaro C, Omlin A, McNamara
MG, Leibowitz-Amit R, Vera-Badillo FE, Attard G, de Bono JS,
Tannock IF and Amir E: Simple prognostic score for metastatic
castration-resistant prostate cancer with incorporation of
neutrophil-to-lymphocyte ratio. Cancer. 120:3346–3352. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szkandera J, Gerger A, Liegl-Atzwanger B,
Absenger G, Stotz M, Friesenbichler J, Trajanoski S, Stojakovic T,
Eberhard K, Leithner A and Pichler M: The lymphocyte/monocyte ratio
predicts poor clinical outcome and improves the predictive accuracy
in patients with soft tissue sarcomas. Int J Cancer. 135:362–370.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rambaldi A, Boschini C, Gritti G, Delaini
F, Oldani E, Rossi A, Barbui AM, Caracciolo D, Ladetto M, Gueli A,
et al: The lymphocyte to monocyte ratio improves the IPI-risk
definition of diffuse large B-cell lymphoma when rituximab is added
to chemotherapy. Am J Hematol. 88:1062–1067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang Y and Feng JF: Low preoperative
lymphocyte to monocyte ratio predicts poor cancer-specific survival
in patients with esophageal squamous cell carcinoma. Onco Targets
Ther. 8:137–145. 2015.PubMed/NCBI
|
|
25
|
Gripp S, Moeller S, Bölke E, Schmitt G,
Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M and
Willers R: Survival prediction in terminally ill cancer patients by
clinical estimates, laboratory tests and self-rated anxiety and
depression. J Clin Oncol. 25:3313–3320. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Claude L, Perol D, Ray-Coquard I, Petit T,
Blay JY, Carrie C and Bachelot T: Lymphopenia: A new independent
prognostic factor for survival in patients treated with whole brain
radiotherapy for brain metastases from breast carcinoma. Radiother
Oncol. 76:334–339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Le Scodan R, Massard C, Jouanneau L,
Coussy F, Gutierrez M, Kirova Y, Lerebours F, Labib A and
Mouret-Fourme E: Brain metastases from breast cancer: Proposition
of new prognostic score including molecular subtypes and treatment.
J Neurooncol. 106:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Keizman D, Ish-Shalom M, Huang P,
Eisenberger MA, Pili R, Hammers H and Carducci MA: The association
of pre-treatment neutrophil to lymphocyte ratio with response rate,
progression free survival and overall survival of patients treated
with sunitinib for metastatic renal cell carcinoma. Eur J Cancer.
48:202–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng
SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ and Khoury JD:
Stage, age, and EBV status impact outcomes of plasmablastic
lymphoma patients: A clinicopathologic analysis of 61 patients. J
Hematol Oncol. 8:652015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kao SC, Vardy J, Chatfield M, Corte P,
Pavlakis N, Clarke C, van Zandwijk N and Clarke S: Validation of
prognostic factors in malignant pleural mesothelioma: A
retrospective analysis of data from patients seeking compensation
from the New South Wales dust diseases board. Clin Lung Cancer.
14:70–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han LH, Jia YB, Song QX, Wang JB, Wang NN
and Cheng YF: Prognostic significance of preoperative
lymphocyte-monocyte ratio in patients with resectable esophageal
squamous cell carcinoma. Asian Pac J Cancer Prev. 16:2245–2250.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng J, Zhang R, Pan Y, Ding X, Cai M, Liu
Y, Liu H, Bao T, Jiao X, Hao X and Liang H: Tumor size as a
recommendable variable for accuracy of the prognostic prediction of
gastric cancer: A retrospective analysis of 1,521 patients. Ann
Surg Oncol. 22:565–572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park JW, Lim SB, Kim DY, Jung KH, Hong YS,
Chang HJ, Choi HS and Jeong SY: Carcinoembryonic antigen as a
predictor of pathologic response and a prognostic factor in locally
advanced rectal cancer patients treated with preoperative
chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys.
74:810–817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hotta T, Takifuji K, Yokoyama S, Matsuda
K, Oku Y, Nasu T, Ieda J, Yamamoto N, Iwamoto H, Takei Y, et al:
Impact of the post/preoperative serum CEA ratio on the survival of
patients with rectal cancer. Surg Today. 44:2106–2115. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Davidson NG, Khanna S, Kirwan PH and
Bircumshaw D: Prechemotherapy serum CA125 level as a predictor of
survival outcome in epithelial carcinoma of the ovary. Clin Oncol
(R Coll Radiol). 3:32–36. 1991. View Article : Google Scholar : PubMed/NCBI
|
